We are a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical need.
$14.00 - $16.00
June 20, 2019
J.P. MORGAN SECURITIES LLC,ROTH CAPITAL PARTNERS, LLC
This offering is no longer available
Sign Up to participate in future offerings
To view the prospectus for Akero Therapeutics IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277